FDA recall D-0650-2017
Lupin Pharmaceuticals Inc. · Class III · drug
Product
Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09
Reason for recall
Failed Impurities/Degradation Specifications; Impurity A
Distribution
Nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2015-12-07
- Report date
- 2017-04-12
- Termination date
- 2017-04-10
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Baltimore, MD, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0650-2017